GeniPhys

GeniPhys is developing and commercializing its patented Collymer technology, a polymerizable collagen that supports custom design and fabrication of collagen scaffolds.

GeniPhys secures FDA 510(k) clearance for its **Collymer Self-Assembling Scaffold (SAS)**, a first-of-its-kind regenerative collagen biomaterial. The product targets advanced wound care applications, leveraging self-assembling technology for potential clinical use. GeniPhys focuses on developing next-generation polymeric biomaterials for tissue regeneration.

Jul 2025Stories - Advancing the Mission of Purdue UniversityNews article

A new flowable collagen liquid, the first of its kind, fills tissue defects and voids in medical procedures. The material integrates seamlessly with surrounding tissue, offering a potential advancement in wound care and surgical applications. Hospimedica highlights its use in critical care for repairing structural gaps without traditional sutures or grafts.

Nov 2024Hospimedica.comNews article

GeniPhys secures a **$500,000 NSF SBIR Phase IIB supplemental grant** to advance its regenerative biomaterials for soft tissue repair. The preclinical-stage company focuses on developing innovative solutions to address soft tissue restoration challenges. This funding supports further research and development in biomaterial innovation.

Oct 2024NewsNews article

GeniPhys, founded by Dr. Sherry Harbin, a Purdue University professor in veterinary medicine and biomedical engineering, has raised **$6 million** in its initial funding round. The company leverages expertise from Purdue’s College of Veterinary Medicine and Weldon School of Biomedical Engineering. The investment supports development of technologies at the intersection of veterinary and biomedical research.

Mar 2023College of Veterinary MedicineNews article